BTIG Downgrades Progyny to Neutral
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst David Larsen has downgraded Progyny (NASDAQ:PGNY) from Buy to Neutral.

August 07, 2024 | 8:54 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BTIG analyst David Larsen has downgraded Progyny from Buy to Neutral, which may lead to a short-term negative impact on the stock price.
The downgrade from Buy to Neutral by a reputable analyst like David Larsen at BTIG is likely to cause a short-term negative impact on Progyny's stock price as investors may perceive this as a signal to reduce their positions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100